Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors: supplementary presentation

Goh SSL 1 , Lai PSM 2 , Tan ATB 3 , Ponnampalavanar S 4

Affiliations 

  • 1 Department of Primary Care Medicine, University of Malaya Primary Care Research Group, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 2 Department of Primary Care Medicine, University of Malaya Primary Care Research Group, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. plai@ummc.edu.my
  • 3 Department of Medicine (Endocrine), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 4 Department of Medicine (Infectious Disease), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
Osteoporos Int, 2018 07;29(7):1683.
PMID: 29737369 DOI: 10.1007/s00198-018-4379-y

Abstract

A meta-analysis was conducted to evaluate the prevalence of osteopenia/osteoporosis in human immunodeficiency virus (HIV)-infected individuals. The prevalence of osteopenia/osteoporosis in HIV-infected and antiretroviral therapy (ART)-treated individuals was significantly higher than respective controls. Evidence regarding bone loss within first year of HIV infection or ART initiation was preliminary.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications